153 related articles for article (PubMed ID: 8075860)
1. Comparison of the ability of nicardipine, theophylline and zaprinast to restore cardiovascular haemodynamics following inhibition of nitric oxide synthesis.
Herity NA; Allen JD; Silke B; Adgey AA
Br J Pharmacol; 1994 Jun; 112(2):423-8. PubMed ID: 8075860
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ability of levcromakalim and sodium nitroprusside to reverse the cardiovascular effects of nitric oxide synthase inhibition in the anaesthetised pig.
Herity NA; Allen JD; Silke B; Adgey AA
Cardiovasc Res; 1994 Jun; 28(6):894-900. PubMed ID: 7522965
[TBL] [Abstract][Full Text] [Related]
3. Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed.
McMahon TJ; Ignarro LJ; Kadowitz PJ
J Appl Physiol (1985); 1993 Apr; 74(4):1704-11. PubMed ID: 8390441
[TBL] [Abstract][Full Text] [Related]
4. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904
[TBL] [Abstract][Full Text] [Related]
7. L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs.
Alemayehu A; Lock KR; Coatney RW; Chou CC
Br J Pharmacol; 1994 Jan; 111(1):205-12. PubMed ID: 8012697
[TBL] [Abstract][Full Text] [Related]
8. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
Thusu KG; Morin FC; Russell JA; Steinhorn RH
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
[TBL] [Abstract][Full Text] [Related]
9. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat.
Bower EA; Law AC
Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632
[TBL] [Abstract][Full Text] [Related]
10. Effects of phosphodiesterase inhibitors on hypoxic pulmonary vasoconstriction. Influence of K(+) channels and nitric oxide.
Goirand F; Bardou M; Dumas J; Rochette L; Dumas M
Eur J Pharmacol; 2001 Apr; 417(1-2):141-8. PubMed ID: 11301069
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of pressor and haemodynamic effects of NG-nitro-L-arginine by halothane.
Wang YX; Abdelrahman A; Pang CC
J Cardiovasc Pharmacol; 1993 Oct; 22(4):571-8. PubMed ID: 7505359
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia.
Cohen RI; Shapir Y; Chen L; Scharf SM
Crit Care Med; 1998 Apr; 26(4):738-47. PubMed ID: 9559613
[TBL] [Abstract][Full Text] [Related]
13. L-Arginine, a precursor of EDRF in vitro, produces pulmonary vasodilation in lambs.
Fineman JR; Chang R; Soifer SJ
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1563-9. PubMed ID: 1659228
[TBL] [Abstract][Full Text] [Related]
14. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
[TBL] [Abstract][Full Text] [Related]
15. Overall hemodynamic studies after the chronic inhibition of endothelial-derived nitric oxide in rats.
Huang M; Manning RD; LeBlanc MH; Hester RL
Am J Hypertens; 1995 Apr; 8(4 Pt 1):358-64. PubMed ID: 7619348
[TBL] [Abstract][Full Text] [Related]
16. NG-nitro L-arginine methyl ester: systemic and pulmonary haemodynamics, tissue blood flow and arteriovenous shunting in the pig.
van Gelderen EM; Den Boer MO; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):417-23. PubMed ID: 8277978
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus.
Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
Am J Physiol; 1995 Aug; 269(2 Pt 2):H473-9. PubMed ID: 7653611
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.
Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ
Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345
[TBL] [Abstract][Full Text] [Related]
19. Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetised rats.
Ng SS; Pang CC
Eur J Pharmacol; 1998 Jun; 351(3):323-8. PubMed ID: 9721024
[TBL] [Abstract][Full Text] [Related]
20. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
Weiss HR; Rodriguez E; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
